1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Anoxia, Brain

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Anoxia, Brain in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (60.00)	18.2507
2000's	2 (40.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Palmer, C	1
Barks, JD; Eun, BL; Liu, XH; Silverstein, FS	1
Akisü, M; Coker, I; Hüseyinov, A; Kültürsay, N	1
Barks, JD; Eun, BL; Liu, XH	1
Cui, XF; Hatakeyama, M; Imaizumi, T; Kimura, D; Kumagai, M; Matsumiya, T; Sakaki, H; Sato, Y; Satoh, K; Shibata, T; Tamo, W; Tanji, K; Yoshida, H	1

Reviews

1 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Anoxia, Brain

Article	Year
Hypoxic-ischemic encephalopathy. Therapeutic approaches against microvascular injury, and role of neutrophils, PAF, and free radicals. Clinics in perinatology, 1995, Volume: 22, Issue:2 Topics: Animals; Antioxidants; Asphyxia Neonatorum; Brain; Brain Damage, Chronic; Brain Ischemia; Cats; Cerebrovascular Circulation; Free Radicals; Humans; Hypoxia, Brain; Infant, Newborn; Microcirculation; Neutrophils; Platelet Activating Factor; Rats; Reperfusion Injury	1995

Article

Year

Hypoxic-ischemic encephalopathy. Therapeutic approaches against microvascular injury, and role of neutrophils, PAF, and free radicals.

Clinics in perinatology, 1995, Volume: 22, Issue:2

Topics: Animals; Antioxidants; Asphyxia Neonatorum; Brain; Brain Damage, Chronic; Brain Ischemia; Cats; Cerebrovascular Circulation; Free Radicals; Humans; Hypoxia, Brain; Infant, Newborn; Microcirculation; Neutrophils; Platelet Activating Factor; Rats; Reperfusion Injury

1995

Other Studies

4 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Anoxia, Brain

Article	Year
The platelet-activating factor antagonist BN 52021 attenuates hypoxic-ischemic brain injury in the immature rat. Pediatric research, 1996, Volume: 40, Issue:6 Topics: Animals; Animals, Newborn; Brain; Cerebral Cortex; Corpus Striatum; Diterpenes; Excitatory Amino Acid Agonists; Fibrinolytic Agents; Functional Laterality; Ginkgolides; Hippocampus; Hypoxia, Brain; Ischemic Attack, Transient; Lactones; N-Methylaspartate; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Time Factors	1996
Platelet-activating factor is an important mediator in hypoxic ischemic brain injury in the newborn rat. Flunarizine and Ginkgo biloba extract reduce PAF concentration in the brain. Biology of the neonate, 1998, Volume: 74, Issue:6 Topics: Animals; Brain; Brain Ischemia; Calcium Channel Blockers; Female; Flunarizine; Ginkgo biloba; Hypoxia, Brain; Male; Plant Extracts; Plants, Medicinal; Platelet Activating Factor; Rats; Rats, Wistar	1998
Platelet-activating factor antagonist BN 50730 attenuates hypoxic-ischemic brain injury in neonatal rats. Pediatric research, 2001, Volume: 49, Issue:6 Topics: Animals; Animals, Newborn; Azepines; Brain Injuries; Brain Ischemia; Cerebral Cortex; Corpus Striatum; Hippocampus; Hypoxia, Brain; Learning; Memory; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Thienopyridines; Triazoles	2001
Platelet-activating factor enhances the expression of vascular endothelial growth factor in normal human astrocytes. Brain research, 2002, Jul-19, Volume: 944, Issue:1-2 Topics: Anti-Inflammatory Agents; Astrocytes; Brain; Cells, Cultured; Cycloheximide; Deferoxamine; Dexamethasone; Dose-Response Relationship, Drug; Endothelial Growth Factors; Gene Expression Regulation; Humans; Hypoxia, Brain; Iron Chelating Agents; Lymphokines; Nerve Degeneration; Neurons; Platelet Activating Factor; Protein Synthesis Inhibitors; RNA, Messenger; Time Factors; Up-Regulation; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors	2002